NXTS today
$2.10-$0.20 (-8.70%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bullish
15 minLeaning Bullish
5 minConsolidating
Daily trend turns up above $0.71
Key levels
Resistance$3.92
Resistance$3.38
Support$1.66
Support$1.14
Latest news & SEC filings
NewsNexentis Technologies plans share consolidation at five-to-one ratio
NewsNexentis Technologies to consolidate shares five-to-one on November 9
ProductNexentis unit MitoCareX Bio finishes first computational screening using Boltz
ProductNexentis unit MitoCareX Bio wraps first screening phase in Boltz collaboration
All NXTS news →About Nexentis Technologies
Nexentis Technologies operates in two areas: oncology biotechnology and renewable energy. Its MitoCareX Bio subsidiary pursues drug discovery for cancer and metabolic inflammatory conditions, targeting proteins in the SLC25A mitochondrial carrier family, with lung and pancreatic cancers as its main focus. The Solterra subsidiary develops solar photovoltaic installations across Europe and sells them to buyers at differing stages of development.
Based on the company's 10-K filed Mar 31, 2026.
NASDAQ · Consumer Defensive
N2OFF, Inc. (NXTS)
What Is the Price Target for NXTS?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is NXTS a Buy or Sell Right Now?
Thesis
- •Revenue growing -20.3% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NXTS.
Start Free Trial →Is NXTS Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$0.52
15
Moat Score
NONE
2/9
Piotroski Score
-10.7
Altman Z-Score
What Is Smart Money Doing with NXTS?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Itzhaik Asaf | director | Buy | 14,795 | - | Oct 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NXTS Growth Story
Revenue YoY
-20.3%
3yr Revenue CAGR
-21.7%
EPS Growth YoY
83.65%
FCF Growth YoY
-5.8%
Revenue Trend
DECLINING
Dark Pool Trades for NXTS
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NXTS, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:52:39 | $2.30 | 1,000 | $$2K | BUY |
| 19:22:29 | $2.56 | 1,000 | $$3K | BUY |
| 16:13:29 | $2.56 | 1,000 | $$3K | BUY |
| 15:57:51 | $2.60 | 1,774 | $$5K | SELL |
| 15:50:58 | $2.62 | 1,000 | $$3K | BUY |
5 dark pool trades shown · $$15K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for N2OFF, Inc. (NXTS) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NXTS — frequently asked questions
What is NXTS stock price today?
N2OFF, Inc. (NXTS) is at $2.10, down 8.70% (-$0.20) at the Nov 12, 2026 close.
Why is NXTS stock moving today?
Latest NXTS news — Nov 7, 2026: Nexentis Technologies plans share consolidation at five-to-one ratio · Nov 5, 2026: Nexentis Technologies to consolidate shares five-to-one on November 9
Did NXTS beat earnings?
NXTS last reported on Aug 13, 2026: EPS -$25.96.
Does NXTS pay a dividend?
NXTS does not currently pay a dividend.
How much debt does NXTS have?
N2OFF, Inc. reported $0M of debt and $2M of cash (Dec 31, 2024).
What are NXTS support and resistance levels?
Support: $1.66, $1.14, $0.51. Resistance: $3.38, $3.92, $4.45.
What are insiders doing with NXTS?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on NXTS?
Nov 7, 2026: Nexentis Technologies plans share consolidation at five-to-one ratio · Nov 5, 2026: Nexentis Technologies to consolidate shares five-to-one on November 9 · Oct 28, 2026: Nexentis unit MitoCareX Bio finishes first computational screening using Boltz